EVA; A novel therapeutic targeting Rationale for the Treatment of Glioblastoma.

被引：0
|
作者：
Rusch, Tillmann [1 ]
Zhao, Kai [2 ]
Neubauer, Andreas [1 ]
Nimsky, Christopher [2 ]
Bartsch, Joerg [2 ]
机构：
[1] UKGM Giessen & Marburg, Standort Marburg, Klin Hamatol Onkol & Immunol, Marburg, Germany
[2] UKGM Giessen & Marburg, Standort Marburg, Klin Neurochirurgie, Marburg, Germany
来源：
INNERE MEDIZIN | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P16-10
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [31] Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?
    Fathpour, Pakzad
    Obad, Nina
    Espedal, Heidi
    Stieber, Daniel
    Keunen, Olivier
    Sakariassen, Per O.
    Niclou, Simone P.
    Bjerkvig, Rolf
    NEURO-ONCOLOGY, 2014, 16 (05) : 754 - 756
  • [32] Trend in incidence, first course of treatment, and survival in patients with glioblastoma.
    Yang, Eunyoung
    Egorova, Natalia
    Moskowitz, Gil
    Bickell, Nina A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches
    Alorfi, Nasser M.
    Ashour, Ahmed M.
    Alharbi, Adnan S.
    Alshehri, Fahad S.
    MEDICINE, 2024, 103 (21) : E38245
  • [34] Novel neutrophil targeting platforms in treating Glioblastoma: Latest evidence and therapeutic approaches
    Zhong, Rui
    He, Hongmei
    Wang, Xiande
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 150
  • [35] Training an immuno-army: Exploiting immunoengineering for the treatment of glioblastoma.
    Ferber, Shiran
    Cryer, Alexander M.
    Gorelick, Noah
    Tyler, Betty
    Brem, Henry
    Langer, Robert S.
    Artzi, Natalie
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 45 - 45
  • [36] Pharmacological targeting of one-carbon metabolism as a novel therapeutic strategy for glioblastoma
    Sun, Yanfei
    Mu, Guangjing
    Xue, Zhiwei
    Li, Xingang
    Lin, Xiaoying
    Han, Mingzhi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [37] Targeting Histone Deacetylase-7 as a Novel Therapeutic Strategy for Glioblastoma Multiforme
    Hassan, Ola
    Karambizi, David
    Tapinos, Nikos
    FASEB JOURNAL, 2022, 36
  • [38] Pharmacological Targeting Of Transgelin-2 As A Novel Strategy Of Therapeutic Intervention In Glioblastoma
    Kumar, A.
    Rajasekera, P.
    Beyer, S.
    McElroy, J.
    Grosu, A.
    Biehn, S.
    Cui, T.
    Becker, A.
    Johnson, B.
    Sebastian, E.
    Lindert, S.
    Bell, E. H.
    Haque, S. J.
    Chakravarti, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E719 - E720
  • [39] Serine/Threonine Kinase 17A Is a Novel Candidate for Therapeutic Targeting in Glioblastoma
    Mao, Pingping
    Hever-Jardine, Mary P.
    Rahme, Gilbert J.
    Yang, Eric
    Tam, Janice
    Kodali, Anita
    Biswal, Bijesh
    Fadul, Camilo E.
    Gaur, Arti
    Israel, Mark A.
    Spinella, Michael J.
    PLOS ONE, 2013, 8 (11):
  • [40] ShRNA-based cellular proliferation signaling analysis revealed DRD2 as a novel therapeutic target for glioblastoma.
    Li, Jie
    Zhu, Shan
    Kozono, David
    Futulan, Diahnn
    Gonda, David
    Kushwaha, Deepa
    Kahle, Kristopher
    Elledge, Stephen
    Chen, Clark C.
    CANCER RESEARCH, 2013, 73 (08)
12345